Accessibility Tools

Shared Care Guidelines


ADHD/Hyperkinetic Disorder for Children & Young People (6-17 years) – Shared care agreement: Methylphenidate, Atomoxetine, Dexamfetamine, Lisdexamfetamine and Guanfacine


Applicable for patients within BLMK area who are under the care of a specialist at East London NHS Foundation Trust (ELFT)

Updated and approved by BLMK APC Jan 2023

View Document

Guideline Categories: Mental Health

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: adhd, Atomoxetine, attention, Dexamfetamine, guanfacine, hyperactivity, Lisdexamfetamine, methylphenidate

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net